FDAnews Drug Daily Bulletin

Sanofi Pulls Leukaemia Drug Ahead of Possible OK for Lemtrada

Aug. 21, 2012
Sanofi's rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.
Yahoo! Finance